control protein Search Results


94
Boster Bio cdk1
Cdk1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk1/product/Boster Bio
Average 94 stars, based on 1 article reviews
cdk1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
Aviva Systems serum high sensitivity c reactive protein hs crp levels
Serum High Sensitivity C Reactive Protein Hs Crp Levels, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serum high sensitivity c reactive protein hs crp levels/product/Aviva Systems
Average 93 stars, based on 1 article reviews
serum high sensitivity c reactive protein hs crp levels - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Aviva Systems il 6
Il 6, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 6/product/Aviva Systems
Average 93 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Rockland Immunochemicals 001 c09

001 C09, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/001 c09/product/Rockland Immunochemicals
Average 92 stars, based on 1 article reviews
001 c09 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

92
Rockland Immunochemicals 001 c19

001 C19, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/001 c19/product/Rockland Immunochemicals
Average 92 stars, based on 1 article reviews
001 c19 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

88
Rockland Immunochemicals length mad2 protein
Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and <t>Mad2.</t> For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.
Length Mad2 Protein, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/length mad2 protein/product/Rockland Immunochemicals
Average 88 stars, based on 1 article reviews
length mad2 protein - by Bioz Stars, 2026-04
88/100 stars
  Buy from Supplier

93
Rockland Immunochemicals rhodamine
Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and <t>Mad2.</t> For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.
Rhodamine, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhodamine/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
rhodamine - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals glutathione s transferase fusion protein
Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and <t>Mad2.</t> For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.
Glutathione S Transferase Fusion Protein, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glutathione s transferase fusion protein/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
glutathione s transferase fusion protein - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Aviva Systems il 4
Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and <t>Mad2.</t> For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.
Il 4, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 4/product/Aviva Systems
Average 90 stars, based on 1 article reviews
il 4 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Rockland Immunochemicals gfp fusion protein
Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and <t>Mad2.</t> For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.
Gfp Fusion Protein, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfp fusion protein/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
gfp fusion protein - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Rockland Immunochemicals red fluorescent protein rfp
Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and <t>Mad2.</t> For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.
Red Fluorescent Protein Rfp, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/red fluorescent protein rfp/product/Rockland Immunochemicals
Average 92 stars, based on 1 article reviews
red fluorescent protein rfp - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

92
Rockland Immunochemicals outer surface protein c ospc protein
Fig. 2: Borrelia <t>OspC-</t> and VlsE-specific IgG combined with sialic acid abundance identifies acute Lyme disease patients. (a) Example of traditional detection of Borrelia burgdorferi (Bb) antigen-specific antibodies using a fluorescent reporter created with BioRender. (b) Example of GlycoLyme method detects a multiplexed sialic acid content and anti-IgG signal in a Bb antigen-specific antibody population created with BioRender. (c) Comparison of IgG abundance from non-Lyme-endemic healthy controls (NLEHC) n = 96, Lyme-endemic healthy controls (LEHC) n = 111, acute Lyme disease (ALD) n = 89, treated Lyme disease (TLD) n = 50, rheumatoid arthritis (RA) n = 20, lupus (L) n = 20, syphilis (S) n = 20, and fibromyalgia (F) n = 20. (d) Comparison of GlycoLyme [anti-OspC/VlsE IgG*SNA] scores from non-Lyme-endemic healthy controls (NLEHC) n = 96, Lyme-endemic healthy controls (LEHC) n = 111, acute Lyme disease (ALD) n = 89, treated Lyme disease (TLD) n = 50, rheumatoid arthritis (RA) n = 20, lupus (L) n = 20, syphilis (S) n = 20, and fibromyalgia (F) n = 20. (e) Receiver operating characteristic (ROC) curve compares ALD to non-ALD (NLEHC, LEHC, RA, L, S, F) with and without accounting for sialic acid abundance using the GlycoLyme method was analyzed with DeLong’s test to determine statical significance with ***p < 0.001. (f) Comparison of n = 35 GlycoLyme score positive ALD with matching TLD timepoint Bb-specific IgG abundance. (g) Comparison of n = 35 GlycoLyme score positive ALD with TLD time point Bb- specific immunoglobulin SNA fluorescence. Error bars present the mean ± standard deviation (SD). Statistical significance was determined using an ordinary one-way ANOVA with Tukey’s multiple comparisons test with ***p < 0.001 for figures (a and b), while paired two-tailed student’s t-test determined significance for figures (f and g) with ****p < 0.0001 and ns = not significant.
Outer Surface Protein C Ospc Protein, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/outer surface protein c ospc protein/product/Rockland Immunochemicals
Average 92 stars, based on 1 article reviews
outer surface protein c ospc protein - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

Image Search Results


Journal: iScience

Article Title: Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis

doi: 10.1016/j.isci.2024.108804

Figure Lengend Snippet:

Article Snippet: Arp37 , Rockland , Cat# 000-001-C09.

Techniques: Recombinant, Produced, Generated, Software, Luminex

Journal: iScience

Article Title: Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis

doi: 10.1016/j.isci.2024.108804

Figure Lengend Snippet:

Article Snippet: CRASP2 , Rockland , Cat# 000-001-C19.

Techniques: Recombinant, Produced, Generated, Software, Luminex

Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and Mad2. For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.

Journal: The Journal of Cell Biology

Article Title: Aurora A kinase phosphorylates Hec1 to regulate metaphase kinetochore–microtubule dynamics

doi: 10.1083/jcb.201707160

Figure Lengend Snippet: Hec1 S69 is phosphorylated throughout mitosis. (A) Amino acid sequences of the human and PtK1 cell Hec1 N-terminal tail domain. Shown in yellow is the human peptide sequence that was used to generate the S69 phosphospecific antibody. The arrow points to S69 in the human sequence and the corresponding serine residue in the PtK1 sequence. Asterisks indicate all other mapped Aurora B kinase sites in the human Hec1 tail domain ( ; ). (B) Immunofluorescence images of HeLa cells stained with phosphospecific antibodies to Hec1 pS69. Depletion of Hec1 (bottom) results in loss of pS69 staining at kinetochores. Cells are also immunostained with antibody 9G3 (pan-Hec1 antibody) and an anticentromere antibody (ACA) derived from human calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) patient serum. (C) Immunofluorescence images of HeLa cells demonstrating kinetochore localization of pS69 during mitosis. Quantification is shown on the right. For each phase shown, ≥400 kinetochores from ≥30 cells were measured. (D) Immunofluorescence images of a HeLa cell stained with antibodies to pS69 and Mad2. For the cell shown, most chromosomes are aligned at the spindle equator, and one chromosome remains near a spindle pole (arrows). A schematic illustrating examples of pole-proximal chromosomes is shown on the left. (E) Immunofluorescence images of HeLa cells depleted of CENP-E to increase the number of pole-proximal chromosomes (arrows) and stained with Hec1 phosphospecific antibodies. Quantification is shown on the right from one representative experiment. n values are as follows: pS69, 20 polar kinetochores and 40 aligned kinetochores; pS55, 17 polar kinetochores and 57 aligned kinetochores; and pS44, 13 polar kinetochores and 29 aligned kinetochores. Error bars indicate SD. Bars: (B, C, and E) 10 µm; (D) 3 µm.

Article Snippet: Two rabbits were immunized with the Mad2 protein (Rockland Immunochemicals Inc), and antisera from the two injected rabbits were affinity purified against full-length Mad2 protein using a HiTrap-NHS column.

Techniques: Sequencing, Residue, Immunofluorescence, Staining, Derivative Assay

Fig. 2: Borrelia OspC- and VlsE-specific IgG combined with sialic acid abundance identifies acute Lyme disease patients. (a) Example of traditional detection of Borrelia burgdorferi (Bb) antigen-specific antibodies using a fluorescent reporter created with BioRender. (b) Example of GlycoLyme method detects a multiplexed sialic acid content and anti-IgG signal in a Bb antigen-specific antibody population created with BioRender. (c) Comparison of IgG abundance from non-Lyme-endemic healthy controls (NLEHC) n = 96, Lyme-endemic healthy controls (LEHC) n = 111, acute Lyme disease (ALD) n = 89, treated Lyme disease (TLD) n = 50, rheumatoid arthritis (RA) n = 20, lupus (L) n = 20, syphilis (S) n = 20, and fibromyalgia (F) n = 20. (d) Comparison of GlycoLyme [anti-OspC/VlsE IgG*SNA] scores from non-Lyme-endemic healthy controls (NLEHC) n = 96, Lyme-endemic healthy controls (LEHC) n = 111, acute Lyme disease (ALD) n = 89, treated Lyme disease (TLD) n = 50, rheumatoid arthritis (RA) n = 20, lupus (L) n = 20, syphilis (S) n = 20, and fibromyalgia (F) n = 20. (e) Receiver operating characteristic (ROC) curve compares ALD to non-ALD (NLEHC, LEHC, RA, L, S, F) with and without accounting for sialic acid abundance using the GlycoLyme method was analyzed with DeLong’s test to determine statical significance with ***p < 0.001. (f) Comparison of n = 35 GlycoLyme score positive ALD with matching TLD timepoint Bb-specific IgG abundance. (g) Comparison of n = 35 GlycoLyme score positive ALD with TLD time point Bb- specific immunoglobulin SNA fluorescence. Error bars present the mean ± standard deviation (SD). Statistical significance was determined using an ordinary one-way ANOVA with Tukey’s multiple comparisons test with ***p < 0.001 for figures (a and b), while paired two-tailed student’s t-test determined significance for figures (f and g) with ****p < 0.0001 and ns = not significant.

Journal: EBioMedicine

Article Title: Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease.

doi: 10.1016/j.ebiom.2024.104979

Figure Lengend Snippet: Fig. 2: Borrelia OspC- and VlsE-specific IgG combined with sialic acid abundance identifies acute Lyme disease patients. (a) Example of traditional detection of Borrelia burgdorferi (Bb) antigen-specific antibodies using a fluorescent reporter created with BioRender. (b) Example of GlycoLyme method detects a multiplexed sialic acid content and anti-IgG signal in a Bb antigen-specific antibody population created with BioRender. (c) Comparison of IgG abundance from non-Lyme-endemic healthy controls (NLEHC) n = 96, Lyme-endemic healthy controls (LEHC) n = 111, acute Lyme disease (ALD) n = 89, treated Lyme disease (TLD) n = 50, rheumatoid arthritis (RA) n = 20, lupus (L) n = 20, syphilis (S) n = 20, and fibromyalgia (F) n = 20. (d) Comparison of GlycoLyme [anti-OspC/VlsE IgG*SNA] scores from non-Lyme-endemic healthy controls (NLEHC) n = 96, Lyme-endemic healthy controls (LEHC) n = 111, acute Lyme disease (ALD) n = 89, treated Lyme disease (TLD) n = 50, rheumatoid arthritis (RA) n = 20, lupus (L) n = 20, syphilis (S) n = 20, and fibromyalgia (F) n = 20. (e) Receiver operating characteristic (ROC) curve compares ALD to non-ALD (NLEHC, LEHC, RA, L, S, F) with and without accounting for sialic acid abundance using the GlycoLyme method was analyzed with DeLong’s test to determine statical significance with ***p < 0.001. (f) Comparison of n = 35 GlycoLyme score positive ALD with matching TLD timepoint Bb-specific IgG abundance. (g) Comparison of n = 35 GlycoLyme score positive ALD with TLD time point Bb- specific immunoglobulin SNA fluorescence. Error bars present the mean ± standard deviation (SD). Statistical significance was determined using an ordinary one-way ANOVA with Tukey’s multiple comparisons test with ***p < 0.001 for figures (a and b), while paired two-tailed student’s t-test determined significance for figures (f and g) with ****p < 0.0001 and ns = not significant.

Article Snippet: The resulting UPLC fluorescent trace was analyzed with Empower v3.3.1 software, UPLC trace percent-area was combined with collected MSspectra to identify eluted peaks as described previously.32 Antigen-specific lectin multiplex assay High-binding 96-well plates (Nest Biotechnology, 514201) were incubated with the recombinantly expressed Borrelia burgdorferi (Bb) antigens: Outer Surface Protein C (OspC) protein (Rockland, 000-001-C11) and Variable Lipoprotein Surface-Exposed (VlsE) protein (Rockland, 000-001-C33).

Techniques: Comparison, Standard Deviation, Two Tailed Test